Kekule Pharma ltd

Established in 1984, Kekule Pharma Ltd. operates 3 manufacturing facilities accredited by the US FDA, MFDS South Korea, COFEPRIS, Iran MOH and WHO GMP. With rich experience manufacturing APIs and advanced intermediates and a specialization in oncology APIs, Kekule works with top generic players globally, exporting to more than 30 countries, with facilities audited by several multinational companies and CDMO services available to meet customer requirements. The company supports complete regulatory documentation with cGMP-compliant facilities, and its backward integration into in-house intermediate manufacturing ensures consistent quality and smooth delivery for strong API products including Etoricoxib, Celecoxib, Pantoprazole Sodium, Quetiapine Fumarate and Citalopram HBr.